CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-19 | Pascoe Richard W Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-06-11 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +1,500 | $0.19 | $288 | 47,000 |
| 2020-06-02 | Mickle Travis C President & CEO | Purchase | +110,000 | $0.19 | $21K | 1,888,117 |
| 2020-05-26 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +11,500 | $0.18 | $2K | 45,500 |
| 2020-03-25 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +1,000 | $0.22 | $218 | 34,000 |
| 2020-03-13 | Sangiovanni Timothy J. VP, Corporate Controller | Purchase | +4,000 | $0.20 | $800 | 18,000 |
| 2020-03-11 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +8,000 | $0.25 | $2K | 33,000 |
| 2020-03-10 | Sangiovanni Timothy J. VP, Corporate Controller | Purchase | +10 | $0.25 | $3 | 6,343 |
| 2020-03-10 | Sangiovanni Timothy J. VP, Corporate Controller | Purchase | +7,657 | $0.26 | $2K | 14,000 |
| 2020-03-09 | Sangiovanni Timothy J. VP, Corporate Controller | Purchase | +333 | $0.25 | $83 | 6,333 |
| 2020-03-05 | Mickle Travis C President & CEO | Purchase | +3,000 | $0.33 | $1K | 1,756,117 |
| 2020-03-05 | Mickle Travis C President & CEO | Purchase | +3,000 | $0.33 | $1K | 1,759,117 |
| 2020-03-05 | Mickle Travis C President & CEO | Purchase | +4,500 | $0.33 | $1K | 1,763,617 |
| 2020-03-05 | Mickle Travis C President & CEO | Purchase | +4,500 | $0.33 | $2K | 1,768,117 |
| 2020-03-05 | Mickle Travis C President & CEO | Purchase | +3,000 | $0.33 | $990 | 1,771,117 |
| 2020-03-05 | Mickle Travis C President & CEO | Purchase | +4,500 | $0.33 | $1K | 1,775,617 |
| 2020-03-05 | Mickle Travis C President & CEO | Purchase | +2,500 | $0.33 | $825 | 1,778,117 |
| 2020-02-05 | Guenther Sven EVP, Research & Development | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2020-02-05 | Mickle Travis C President & CEO | Grant or award · Stock Option (right to buy) | +420,000 | 420,000 | ||
| 2020-02-05 | Sangiovanni Timothy J. VP, Corporate Controller | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 |
Page 13 of 16 · 319 trades